Market Research Blog

According to a recent study by Future Market Insights (FMI), the GCC medical gloves market is reached US$ 145 Mn in 2020. With sales growing at a healthy 7.9% CAGR, the market valuation is set to reach US$ 340.3 Mn by 2031.

Modernization of lifestyles in GCC countries has resulted into a rise in elective surgeries which are not crucial for an individual to survive but have more of an optional nature. Elective surgeries like plastic surgery, liposuction, rhinoplasty, breast augmentation, breast reduction, blepharoplasty, etc. have been getting increasingly popular in countries like Dubai and other Gulf countries. These surgeries ultimately require a supply of necessary medical supplies including medical gloves, thereby increasing their demand.

When performing any type of surgeries, chances of glove punctures while using single set of gloves are high. Therefore, professionals use double set of gloves to avoid the possibility of contamination of sterile surgical equipment. These “double gloving” practices are expected to continue boosting sales over the assessment period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GC-1943

Key Takeaways:

• By raw material, the latex material segment is expected to hold 80.2% of the total market share in 2021, expanding at 7.9% CAGR during the forecast period.
• Based on product type, the examination gloves segment is projected to command 55.6% of total sales in 2021, expanding at 8.1% CAGR.
• By form, the powdered form segment is expected to hold 63.7% of the total market share in 2021, expanding at 8.0% CAGR.
• By type of use, sales of disposable gloves are anticipated to hold 90.5% of the total market share 2021, and are to projected to increase at a robust 8.0% CAGR over the forecast period.
• By end use, hospitals will account for 67.2% of total sales in 2021.
• By distribution channel, the direct selling channel will account for 55.1% of the total market share in 2021.
• Kingdom of Saudi Arabia (KSA) is anticipated to hold the largest share of 76.2% of the GCC medical gloves market in 2021.

Who is winning?

Leading players operating in the market are investing in mergers, acquisitions and collaborations with existing players and healthcare institutes to gain a competitive edge. For instance:

In August 2020, Ansell Healthcare Products LLC collaborated with Nordic company ONeMEd with an aim to expand their customer base in the Nordic countries. Ansell is one of the global leaders in hand protection equipment.

The key market players covered by FMI include Paul Hartmann AG,Hotpack Packaging Industries LLC,Falcon (Falcon Pack),Deeko Bahrain,Salalah Medical Supplies Mfg. Co. LLC,United Medical Industries,NAFA Enterprises Ltd.,Liberty Industries, Inc.,Ansell Healthcare,Mckesson Corporation,Cardinal Health, Inc.,Medline Indsutries, Inc.,Dynarex Corporation,Top Glove Corporation Berhad,Kimberly-Clark Corporation,Semperit AG Holding

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gc-1943

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of hyperparathyroidism-related hypercalcemia and rising incidence of multiple myeloma are major factors expected to fuel growth of the global hypercalcemia treatment market over the forecast period. Availability of drug therapy alternatives over surgeries and favourable reimbursement policies are key factors expected to fuel global market growth.

Hospitals remain the largest distribution channel in the hypercalcemia market in terms of revenue contribution, accounting for around 39% share to the global market in 2015. Rapid diagnosis and easy availability of hypercalcemia drugs are key factors attributed to increasing revenue from the hospitals end user segment, and hospitals are expected to continue to remain the largest distribution channel for hypercalcemia treatment in the long-term.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1320

Bisphosphonates product type segment is estimated to continue to account for relatively higher revenue share to the global market, at over 67% in 2016 end. U.S. FDA approval of denosumab (Xgeva) for treating hypercalcemia of malignancy refractory in 2014 has boosted the use of biophosphonates. Glucocorticoids and calcimimetics segments are also anticipated to witness steady revenue growth in the near future.

North America and Western Europe are among the leading markets for hypercalcemia treatment, with the former accounting for revenue share of 46% in 2015. The North America hypercalcemia treatment market is anticipated to be valued at US$ 4.39 Bn in 2017, up from US$ 3.61 Bn in 2015. The market in North America is dominated by the U.S. Higher prevalence of malignancy-related hypercalcemia among cancer patients in North America will continue to influence market growth in the near future.

Amgen Inc., Novartis AG, and Teva Pharmaceuticals Industries Ltd., Pfizer Inc., and F.Hoffmann-La Roche Ltd. are among the leading players in the global hypercalcemia market. The U.S. remains a lucrative market for majority of leading players; foraying into emerging markets of Asia and Africa is a key focus area for global players.

Long-term Outlook: The global hypercalcemia market is anticipated to register a CAGR of 11.2% in terms of revenue during forecast period 2016–2026, and reach a value of US$ 25.23 Bn by 2026.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1320

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to a recent study by Future Market Insights (FMI), the global balloon catheter market is expected to witness high growth during the forecast period. Sales are expected to reach US$ 5.11 Bn by the end of 2031. This reflects a cumulative CAGR of around 4.0% over the forecast period (2021-2031).

Drug eluting balloons are playing an important role by facilitating the push mechanism, through the drug treatment. Excipient coated balloons offer a high efficacy and viability for the transfer of the drug.

Development in such technologies is increasing the use of balloon catheters, boosting the market. Hence, to gain competitive edge, key players are developing advanced drug eluting balloon.

Subsequently, these companies are getting approvals from the governments to commercially manufacture these balloons. This is expected to bode well for the growth in the market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1916

Furthermore, due to prolonged stay at the hospital in angioplasty procedures, preference for the same is decreasing among patients with coronary artery disease (CAD). Hence, with attributes such as minimal invasion of drug eluting balloon catheters, demand is increasing among CAD patients.

Hence, efforts are being taken by public authorities, NGO’s, and government to spread awareness regarding the positive benefits of balloon catheters. For instance, campaigns such as “Spread the Word Campaign”, educating women on CAD and its treatments solutions by Healthy Women and National Association for Nurse Practitioners.

A slew of such activities are expected to increase the demand for balloon catheters over the forecast period.

Key Takeaways

• By product, normal balloon catheter holds the maximum share of 43.9% in 2021, expanding at 0.8% CAGR during the forecast period.
• By indication, coronary artery disease is anticipated to account for nearly 71.5% market share in terms of value due to the high prevalence of coronary artery diseases across the globe
• By raw material, the nylon segment holds 46.3% of the market share, registering 4.0% CAGR  in 2021
• Polyurethane catheters are expected to hold second-largest share, contributing 34% of overall sales in 2021.
• By end user, the hospital segment will account for 70.5% of the market share in 2021 due to the availability of advanced technology and need for minimally invasive surgical procedures.
• By region, North America held the largest share of 31.7% in the global Balloon Catheter market in 2021.

Who is winning?

Some of the leading manufacturers of balloon catheters market are focusing on product launches for expansion of their product portfolio. They are also aiming for strategic mergers and partnerships, thereby, strengthening their global presence.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1916

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global special purpose needles market is projected to be valued at US$ 17,261.5 million by the end of 2026, registering a CAGR of 7.4% during the forecast period (2016–2026). In a new report titled “Special Purpose Needles Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”, Future Market Insights delivers key insights on the factors and trends impacting the global special purpose needles market over a 10-year forecast period (2016–2026).

The market for special purpose needles is witnessing steady growth across the globe owing to an increasing geriatric population. According to analysts at Future Market Insights, “Increasing prevalence of diabetes and infectious diseases and increasing incidence of cancer and spine disorders across the globe are the primary factors driving the growth of the global special purpose needles market.” Availability of better reimbursement options for some types of special purpose needles in developed economies is likely to propel demand for special purpose needles over the forecast period. A key trend witnessed in the global special purpose needles market is the development of advanced techniques in the production of special purpose needles to facilitate enhanced patient safety and comfort. However, rise in awareness on needle free injections and risks associated with injections are major factors expected to hamper the overall growth of the special purpose needles market over the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-583

The global special purpose needles market can be segmented on the basis of product type (Fine Aspirating Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Implantation Needles, Dental Needles, Ophthalmic Needles, Blood Collection Needles, Spinal Anaesthesia Needles, Epidural Needles, AV Fistula Needles, Cannula Needles); application (Sample Collection, Drug Delivery); and distribution channel (Hospital Pharmacies, Private Clinics,   Retail Pharmacies and Drug Stores, E-Commerce).

Segmentation highlights

• The Pen Needles product type segment is expected to gain popularity over the forecast period, driven by increasing global adoption of small sized needles for insulin injections. The Pen Needles product type segment is estimated to reach a valuation of US$ 644.3 Mn by the end of 2016, registering a CAGR of 9.1% over the forecast period.
• The Sample Collection application segment is estimated to register a CAGR of 7.7% while the Drug Delivery application segment is expected to register a CAGR of 7.1% during the forecast period.
• Demand for special purpose needles over the forecast period is expected to be the highest in the Hospital Pharmacies distribution channel segment, which is expected to register a CAGR of 8.5% in terms of value.

Regional forecast

The North America market has been estimated to dominate the special purpose needles market while the market in APEJ is expected to be the fastest growing in terms of revenue growth. The markets in North America, Western Europe, and APEJ are estimated to collectively hold 74.7% market share of the global special purpose needles market in 2016.

Vendor insights

Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, Boston Scientific Corporation, Novo Nordisk A/S, Argon Medical Devices, Inc., Stryker Corporation, NIPRO Medical Corporation, Cook Medical, and SERAG-WIESSNER GmbH & Co. are some of the major companies operating in the global special purpose needles market. These companies are adopting innovative strategies to bring in improvements to their product design and are initiating advanced R&D activities and market consolidation to strengthen market foothold and expand customer base.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-583

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to a recent study by Future Market Insights (FMI), the GCC syringes and needles market is expected to register high growth during the forecast period. The market is expected to grow from US$ 525.4 Mn in 2020 to over US$ 1.33 Bn by 2031. This reflects a CAGR of around 8.8% over the forecast period (2021-2031).

GCC countries have been prioritizing their healthcare sector owing to the increasing population along with a growing burden of geriatric population. There has been a significant increase in the prevalence of lifestyle disorders and other chronic non-communicable diseases in these countries.

This has resulted in the high demand syringes and needles as systems for accurate drug delivery for the treatment of various chronic ailments.

Government reforms and initiatives have been introduced to improve their healthcare systems and various changes have been made to improve the efficiency and quality of healthcare system in the countries. Favorable policies aimed at expansion of healthcare sector will present conducive environment for the growth of the market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GC-1874

According to an article published in the Saudi Medical Journal, the prevalence of diabetes was around 31.6% in the Kingdom of Saudi Arabia in the year 2017. Furthermore, increasing prevalence of other chronic diseases such as cardiovascular diseases, cancer, and other non-communicable diseases along with diabetes, which require long term care, contribute majorly in the increasing demand for disposable syringes and needles in these countries and will positively impact the market growth over the forecast period.

In February 2021, the Chairman of Department of Health, His Excellency Mohammed Al Hamed visited the Abu Dhabi Medical Devices company’s headquarters factory to oversee the efforts been taken to contribute to the COVID-19 pandemic since the company has made collaborations with various international organizations like UNICEF and COVAX to supply syringes and needles for the vaccination program worldwide.

Such developments not only strengthens the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and helps companies to sustain the increasing competitive pressure. These developments are expected to favor growth of the GCC syringes and needles market.

Key Takeaways from GCC Syringes and Needles Study

• Hypodermic syringes and needles will remain the top-selling product in the market, accounting 87.6% of demand in 2021.
• By usability, the disposable syringes and needles will account for dominant share of 81.3% in the market in 2021.
• By material, the polymer syringes and needles are expected to register high demand. Sales in this category will grow by 8.9% during the forecast period.
• By end user, the hospital segment will account for 66.9% of the market share in 2021.
• By countries, Kingdom of Saudi Arabia (KSA) is anticipated to hold the largest share of 73.6% of the GCC syringes and needles market in 2021.

Who is winning?

Some of the leading manufacturers of syringes and needles market are focusing on product launch, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

The key market players covered by FMI include Becton, Dickinson and Company, Nipro Corporation, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Medtronic PLC, Smiths Group PLC,  Abu Dhabi Medical Devices Company, SAAPP (FZC) LLC. and IBN Sina Medical Factory

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gc-1874

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Wound care management is a billion-dollar market accounting for a massive proportion of the healthcare expenses worldwide. Inter- and intra-departmental collaborations between surgeons and their support staff, i.e. the nurses, plays a key role in better wound management. This also determines the usage pattern for traditional wound management products, order placement cycles and choosing preferred vendors. The application of customer analytics and critical vendor management strategies are factors that are likely to fuel the demand for traditional wound management products, according to the Future Market Insights report on the global traditional wound management market. According to this report, the global traditional wound management market is estimated to expand by 1.4x in terms of value over 2016–2026, to reach a value of US$ 1,792 Mn by the end of 2026.

The gauzes product type segment contributed the highest revenue share in the global traditional wound management market in 2016. The usage of cotton gauze traditional wound management products for medical dressings, bandages, production of wound adhesions and many others is facilitating the growth of this segment in global traditional wound management market. Its non-adherent nature makes it more popular over other traditional wound management products.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-857

Increase in outpatient wound care practices in ambulatory care centers is fuelling the usage of traditional wound management products. Moreover, traditional wound management products are witnessing demand from outpatient centers owing to low cost and easy availability as compared to advanced wound care products. Ambulatory care practices are also increasing due to the preference for minimally invasive or outpatient-based surgeries in the U.S and Europe. The development and incorporation of wound-care curriculum is boosting the usage of traditional wound management products among end users. Discussions with suppliers in the market revealed that the development and incorporation of wound-care curriculum in larger hospitals has improved product consumption/usage. This happens through continued education and rising awareness among caregivers regarding the proper usage of products, thus facilitating effective wound care consistent with the current “best practices.” These factors eventually help ensure best patient experiences as well as develop brand loyalty for traditional wound management products.

The improvement and streamlining of regulatory processes in developing countries is expected to boost the formalisation of practice standards, the development of better clinical treatment guidelines, the standardisation of product usage, and the strengthening of the registration & licensing period required for traditional wound management products. This is expected to help companies operating in the traditional wound management market ensure that their products comply with the quality, safety and hygiene norms designed by nodal regulatory bodies such the U.S. CDC, Australian TGA and U.K. NHS, among others.

Among all regions, North America dominated the global market for traditional wound management and is expected to continue to maintain its dominance. In spite of the availability of more convenient and advanced wound healing products, majority of healthcare professionals opt for the usage of traditional wound management products due to cost-effectiveness and the availability of clear reimbursement policies for these products in countries such as the U.S. The APEJ traditional wound management market is estimated to expand at the highest CAGR over 2016–2026. Decreasing prices of cotton as a raw material for traditional wound management products in countries such as India and China is contributing to the high growth of the APEJ traditional wound management market.

Although traditional wound management constitutes the largest revenue share for total wound management, it is low-margin in nature. Most of the raw materials such as cotton, are exported from developing markets to markets that have a strong manufacturing base and high sales of finished products. Trading of these raw materials in traditional wound management market takes place at subsistence levels as these markets are mostly unorganized in nature. Lack of attractive margins is discouraging retailers from the business of traditional wound management products, and their focus is gradually shifting to the business of advanced wound care management products.

The global traditional wound management market is highly fragmented with a large number of regional and local players operating in the global market. Reimbursement service providers are more focused on providing reliable and cost-effective wound management solution to patients. Payers offering coverage for wound care and wound management are adopting traditional wound management as well as advanced wound care products.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-857

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global excimer and femtosecond ophthalmic lasers market is expected to witness stable growth in 2016, reaching a value of US$ 666 Mn in terms of revenues. Excimer laser systems will continue to outsell femtosecond lasers. North America will remain the top market, whereas Asia Pacific (excluding China and Japan) is anticipated to create a lucrative market for excimer and femtosecond ophthalmic lasers globally.

Pronounced growth in geriatric population and significantly rising prevalence of diabetes will remain the key drivers fuelling the demand for excimer and femtosecond ophthalmic laser systems. Technological advancements in ophthalmic laser technology is anticipated to play a key role in catapulting their popularity and propelling their demand in market.

With refractive and cataract surgeries growing in number, more number of hospitals and ophthalmology clinics are raising demand for ophthalmic laser systems. Rising healthcare awareness and expenditure among developing economies are also expected to drive the market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1717

High costs associated with ophthalmic laser systems may however hamper the market growth. In addition, post-LASIC complications are estimated to remain a longstanding challenge to mass adoption of excimer and femtosecond ophthalmic laser systems.

Based on product type, excimer laser systems will continue to dominate femtosecond lasers throughout 2016. The former is predicted to contribute over 60% to the total market share, whereas the latter will witness significant Y-O-Y growth in 2016. Despite considerable adoption due to persistent technological and functionality advancements, higher costs are expected to hold a negative impact on the femtosecond laser system sales.

On the basis of application, refractive surgery segment is predicted to account for the maximum revenue share of around 70%, in 2016. It will also witness the fastest growth, compared to other segments, including cataract surgery, capsulotomy, trabeculoplasty, and diagnostics. Cataract surgery segment is projected to be the second largest application area, witnessing substantial demand for excimer and femtosecond laser systems.

By end-user, ophthalmology clinics segment accounted for the highest revenues of US$ 279 Mn in 2015. It is estimated to attract hefty revenues in 2016 as well, reaching US$ 291 Mn. Hospitals and ambulatory surgical centres will gain an uptick; whereas multi-chain ophthalmology hospitals are foreseen to gain prominence across the U.S., owing to soaring demand for refractive surgery.

Based on region, North America will remain the leading market and contribute over 30% revenue share to total market revenues by 2016 end. In terms of revenues, the market for excimer and femtosecond ophthalmic laser systems in N.

America is anticipated to reach a value of US$ 217 Mn in 2016, up from US$ 209 Mn in 2015. Western Europe will continue to witness significant adoption of excimer and femtosecond ophthalmic lasers, whereas Asia Pacific excluding China and Japan (APECJ) is projected to provide substantial growth opportunities.

APECJ is expected to remain a major market, owing to rapid improvisation of healthcare infrastructure in the region. China, with the highest growth rate in 2016, will represent the most lucrative market for excimer and femtosecond ophthalmic laser systems.

Key players in the global excimer and femtosecond ophthalmic laser market include Alcon Inc. (Novartis AG), Abbott Medical Optics, Inc., NIDEK CO., LTD, SCHWIND eye-tech-solutions GmbH & Co. KG, ZEISS International, Bausch & Lomb Incorporated, Ziemer Ophthalmic Systems AG, LENSAR, LLC., and iVIS Technologies.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1717

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Clinical Mobility Market Overview

Technological advancements and innovations in the health care industry enables create lucrative opportunities for the companies which are plunged in clinical mobility market. The clinical mobility enhances information flow among the health care providers and patients. Most of the patients face problems retaining information. Clinicians can use mobile health devices to supplement the information as well as mobile application are designed to provide in- depth therapeutic and diseases specific information. The patients can easily search the disease related information. The clinical mobility offers a wide array of advantages, includes telemonitoring, vital signs of geriatric patients, and video conference with care givers and doctors. Software-as-a-Services (SaaS), Platform-as-a-Services (Paas) is gaining the popularity due to enormous advantages in clinical mobility. Smartphones are acts as a universal devices on which various application can be integrated. Visibility solutions enables doctors and nurses to provide the better services to the patients. The global clinical mobility market anticipated to exhibit a significant CAGR as well as annual growth rate over the forecast period.

Clinical Mobility Market: Drivers and restraints

Clinical mobility market can be impacted by following factors, change the trend towards technological advancements and innovations in the health care industry enables increase adoption rate of mobile devices, which proliferate the global clinical mobility market. Increase in the health care expenditure enable adopt advanced technologies such as clinical mobile services and Information technology related services i.e., electronic health records spur the new opportunities for the clinical mobility market. The governments are taking initiative steps to generate and adopt the advanced clinical mobility services have a tremendous impact on clinical mobility market.

However, dearth of skilled professional and cost are act as bottlenecks for global clinical mobility market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1612

Clinical Mobility Market: Overview

Global clinical mobility market is gaining up surge across the globe due to increased awareness among people. The global clinical mobility market is witnessed to unlock the potential over the forecast period.

Clinical Mobility Market: Region-Wise Outlook

Global market is segmented into seven key regions, those are North America (N.A), Latin America (L.A), Eastern Europe (E.E), Western Europe (W.E), Asia-Pacific Excluding Japan (APEJ), Middle East and Africa (MEA), and Japan.

North America is maintaining its stewardship in clinical mobility market due to increased awareness as well as adoption of advanced technologies in health care sector. U.S, Canada has a significant contribution in the global clinical mobility market. Europe is expected to exhibit a robust growth, owing to increased adoption of advanced technologies.  Germany has a significant contribution in European region followed by U.K, Italy, and Belgium. Asia-Pacific region offers a robust market share in global clinical mobility market, owing to the drastic change in Asian countries demographics as well as economy industry in China, Japan, and India. The global clinical mobility market is anticipated to account for significant CAGR as well as lucrative opportunities for the companies over the forecast period.

Clinical Mobility Market: Key players

Some of the key players are Philips Healthcare, Cerner Corporation, Oracle Corporation, AT&T Inc., Cisco Systems, Inc., Zebra Technologies Corporation, Omron Corporation , and Airstrip Technologies, Inc. Microsoft, Inc. Apple, Inc. IBM Corporation, and Verizon Communications, Inc.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1612

The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
• Eastern Europe (Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-1612

Clinical Mobility Market: Segmentation

Global Market can be segmented as following types

Based on Product type

• Products
• Mobile devices
• Mobile Applications
• Services
• Cloud Based Services
• Web Based Services

Based on application

• Patient care
• Work force management
• Operations

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-1612

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Intraosseous Devices Market Overview

Establishment of vascular access is required in case of medical emergency and life-threatening traumatic injuries for the delivery of medications and for fluid replacement, including crystalloids, blood, and blood products. The potential use of this technique called as, intraosseous infusion was established in 1920’s as a rapid, safe and effective method of vascular access through the bone marrow when intravenous attempt fails to establish vascular access. Historically intraosseous infusion (IO) was recommended only in children’s younger than six years whereas now use of IO techniques in patients of all ages is supported by guidelines for cardiopulmonary resuscitation.

Currently there are many intraosseous devices available in the market for the rapid administration of fluids and medications directly into the vascular systems. These devices are inserted directly into the medullary space of bone, and range from manually inserted spinal needles to the impact drivers and drill powered devices. The manually inserted needles have been approved in the U.S. since 1940’s. In addition site of insertion also plays an important role in defining the overall approach in instraosseous infusion. Various sites available for intraosseous insertion includes sternum, distal and proximal tibia, distal femur and calcaneum. The device is quickly inserted and correct placement of the device is confirmed by the flow of intravenous fluid into the device. If at all extravasation of the fluid around the insertion site occurs, the device is removed to prevent development of compartment syndrome. However aspiration of bone marrow represent another approach to confirm the correct placement of the device. One of the fastest and most reliable means of administrating the emergency fluids in the sternum is sternal intraosseous infusion (IO) allowing easy vascular access.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1516

Intraosseous Devices Market: Drivers & Restraints

Intraosseous infusion is primarily used in pre-hospital’s pediatric emergencies where intravenous delivery of fluids and medications is difficult. Increasing prevalence of various diseases forms and growing number of traumatic surgeries are expected to create demand for these devices in the forthcoming years. Additionally introduction of technologically advanced intraosseous devices in the market such as EZ-IO which allows rapid and more reliable emergency vascular access than the available manual techniques in the market. Continual training of medical and nursing staff and well defined protocols regarding proper handling of the device required for effective and safe care of patients undergoing intraosseous venous access is also leading to the rising adoption of these devices in hospitals.

One of the main complication while inserting the intraosseous device is extravasation of fluids and medications into soft tissues which can lead to compartment syndrome (a condition resulting from increased pressure within a confined body space). Other side effects associated with the use of these devices includes iatrogenic fractures, growth plate injury, infection (cellulitis) and osteomyelitis.

Intraosseous Devices Market: Overview

With rising number of traumatic events coupled with failure of intravenous vascular access is expected to fuel the demand for intraosseous devices in the near future. Intraosseous infusion is safe and effective technology in case of cardiopulmonary resuscitation where other route of administration fail to deliver the required effect. Other vascular access procedures such as peripheral venous access is a time consuming procedure thus making it not feasible for cardiopulmonary resuscitation. The intraosseous devices market is expected to grow at a healthy pace over the forecasted period.

For any queries linked with the report, ask an analyst >>

https://www.futuremarketinsights.com/ask-question/rep-gb-1516

Intraosseous Devices Market: Region-wise Outlook

On the basis of region presence, intraosseous devices market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. North America and Europe are the biggest markets for the intraosseous device market. Owing to rapid launch of various technologically advanced intraosseous devices by big manufacturers and increasing incidences of various cardiac disorders are some of the factors expected to pull the growth of these devices in the North American market. In addition macroeconomic factors such as FDA approvals are also expected to increase the adoption rate of such devices in the developed countries. Also big players such as, Pyng Medical Corp., are entering the Asia pacific market by expanding its distribution network which is expected to create market opportunity for the intraosseous device market in Asia Pacific region.

Intraosseous Devices Market: Key Players       

Some of the key market players in the intraosseous devices market are Pyng Medical Corp., PerSys Medical, Aero Healthcare, Vidacare Corporation, Carefusion Inc., Cook Medical Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1516

Intraosseous Devices Market: Segmentation

Intraosseous Devices marketis segmented on basis of technology, route of administration, end user and geography:

By Technology

• Manual
• Automatic
• Impact-Driven
• Powered Drill

By Route of Administration

• Sternum
• Distal and Proximal Tibia
• Distal Femur
• Calcaneus
• Head of Humerus

By End User

• Hospitals
• Ambulatory Surgical Centers
• Cardiology Clinics

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-1516

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com